CA2091443A1 - Medium for culture of mammalian cells - Google Patents

Medium for culture of mammalian cells

Info

Publication number
CA2091443A1
CA2091443A1 CA 2091443 CA2091443A CA2091443A1 CA 2091443 A1 CA2091443 A1 CA 2091443A1 CA 2091443 CA2091443 CA 2091443 CA 2091443 A CA2091443 A CA 2091443A CA 2091443 A1 CA2091443 A1 CA 2091443A1
Authority
CA
Canada
Prior art keywords
per liter
medium
milligrams per
serum
amount
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA 2091443
Other languages
French (fr)
Inventor
Luciano Ramos
Amy A. Murnane
Melvin S. Oka
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Corp
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2091443A1 publication Critical patent/CA2091443A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/0018Culture media for cell or tissue culture
    • C12N5/0037Serum-free medium, which may still contain naturally-sourced components
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00Specific components of cell culture medium
    • C12N2500/05Inorganic components
    • C12N2500/10Metals; Metal chelators
    • C12N2500/20Transition metals
    • C12N2500/24Iron; Fe chelators; Transferrin
    • C12N2500/25Insulin-transferrin; Insulin-transferrin-selenium
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00Specific components of cell culture medium
    • C12N2500/30Organic components
    • C12N2500/34Sugars
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00Specific components of cell culture medium
    • C12N2500/30Organic components
    • C12N2500/36Lipids
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00Specific components of cell culture medium
    • C12N2500/70Undefined extracts
    • C12N2500/74Undefined extracts from fungi, e.g. yeasts

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

The invention provides serum-free media for the culture of mammalian cells comprising a synthetic basal medium designed for mammalian cell culture; about 0.1 to about 10 grams per liter hydrolyzed yeast; about 0.1 to about 5 grams per liter of dextran or albumin; about 2 to about 20 milligrams per liter insulin; 0 to about 100 milligrams per liter of a compound selected from the group consisting of transferrin, ferric fructose, ferrous citrate and ferrous sulfate; and a fatty acid component consisting of oleic acid, linoleic acid and linolenic acid in a ratio of about 0.6: 1:
0.14 milligrams of fatty acid per liter.

Description

W092/05246 PCT/US91tO6837 ~; .
91~3 - MEDI~X FOR C~L~RE OF MAMMA~IAN CELLS

Field of the ~vention The present invention relates to the field of cell culture media. More particularly the invention relates to the field of mammalian cell culture media.
Bac~round of the Invention Beyond a basal nutrient mixture of salts, sugars, amino acids, and vitamins, cells ln vitro have also been found to require for proliferation a supplement of poorly defined biological fluids or extracts. Because of availability and ease of storage, the most commonly used supplement is serum.
The use of serum in cell culture media, however, has several disadvantages. Serum is comparatively expensive.
- Since serum is not a defined component, different lots of serum may vary in the concentration of compounds present and ` thus result in unpredictable culture growth. Serum may also be contaminated with viruses or mycoplasms. The protein in serum may complicate the purification of cell products from the culture medium.
; 20 In efforts to overcome the disadvantages of serum containing medium, researchers have attempted to provide serum-free media by substituting defined or better characterized components for serum. Unfortunately, the complexity of serum and the differing growth requirements of different types of cells has made it difficult to provide such media. For reviews on serum-free media for mammalian cell culture see Rizzino et al. (1979) "Defined Media and the . .

W092~0~246 PCT/US91/06837 Determination of Nutritional and Hormonal Requirements of Mammalian Cells in Culture" Nutrition Reviews 37: 369-378;
Barnes and Sato (1980) "Serum-free Cell Culture: a Unifying Approach`', Cell 22: 649-655; Barnes and Sato (1980) "Methods for Growth of Cultured Cells in Serum-Free Medium", Analyt.
Biochem. 102: 255-270; and Bodeker et al. (1985) "A Screening Method To Develop Serum-Free Culture Media For Adherent Cell Lines", Develop. Biol. Standard. 60: 93-100.
U.S. Patent 4,786,599 issued November 22, 1988 to Chessebeuf and Padieu discloses a serum-free animal tissue culture medium containing a mixture of six fatty acids and albumin or dextran. The medium is particularly adapted for the primary culture of rat liver epithelial cells and possibly in the presence of hormones and/or growth factors, for obtaining cell lines, in particular myeloma and hybridoma cell lines.
Media for the serum-free culture of Chinese hamster ovary cells (CHO) have been reported. Gasser et al (1985) In Vitro Cellular & Developmental Biology 21: 588-592 discloses a serum-free medium for the culture of CHO cells. The serum-free medium is composed of a 1:1 mixture of Ham's F12 and modified Eagle's minimum essential media supplemented with transferrin, insulin, and selenium. Mendiaz et al. (1986) In Vitro Cellular ~ Developmental Biology 22: 66-74 discloses a serum-free medium for the culture of CH0 cells composed of a basal medium supplemented with insulin, and ferric sulfate or transferrin, selenium, trace elements, calcium chloride, glutamine, linoleic acid, non-essential amino acids, and insulin.
Pietrzkowski et al (1988) Folia Histochemica et Cytobiologica 26: 123-132 report a serum-free medium for the culture of chick embryo cells containing dextran.
Pietrz~owski and Xorohoda (1988) Folia Histochemica et Cytobiologica 26: 143-154 report a serum-free medium containing dextran for the culture of chick embryo fibroblasts. In these two publications, the dextran was added to the medium to enhance cell attachment and spreading.

.
: ................. . : .................. :

.~ : . . . : . . ., : , W092/0~246 PCT/US91/06837 ~ ~3~ 2091~43 Ohmori (1988) Journal of Immunological Methods 112: 227-233 reports a serum-free medium which is able to support primary antibody responses by cultured murine lymphocytes. This medium is based on a basal medium supplemented with ~-cyclodextrin, insulin, transferrin, albumin, low densitylipoprotein, putrescine and alanine.
It is an object of the invention to provide serum-free media for the culture of mammalian cells. It is also object of the invention to provide serum-free media for the culture of mammalian cells transformed to produce recom~inant products that increase product yield. It is yet another object of the invention to provide serum-free media for the culture of CHO cells.
8ummary of the Invention The present invention provides media for the culture of mammalian cells. The invention is more particularly pointed out in the appended claims and is described n its preferred embodiments in the following description.
Detailed Deqcription of the Invention The media of the invention are useful for the culture of mammalian cells. The media of the invention have been found to be useful in the culture of Chinese hamster ovary (CHO) cells, and HA~ cells, a baby hamster kidney cell line. The media of the invention have been found not suitable for the culture of myeloma cell lines.
Cells may be grown in batch and continuous culture with the serum-free media of the invention. C~O cells grown in the media of the invention reach higher cell density and show increased recombinant product secretion when compared to CHO cells grown in a serum-containing medium.
The cell culture media of the invention are prepared by adding components to a basal medium designed for mammalian cell culture. The media are prepared in accordance with standard procedures for preparing cell culture media.
Suitable basal media include standard mammalian cell culture media such as Ham's medium, Waymouth MB 752/1 medium, Eagle's medium, Williams E medium, 199 medium and derived ~, .:, ................................... , . ~ , .
;,~
,.~ I ~ ' . ', , ' ' W092t05246 PCT/US91/06837 2091~43 -4~
media of the types MEM and MEM~ and any combinations of these media. Other standard media used for the culture of mammalian cells are also suitable for use in the invention~ A preferred basal medium is the basal medium of Example l. The preferred basal medium supports cell growth and significantly reduces the size of cell clumps in the media during cell culture.
A yeast hydrolysate such as Yeastolate is added to the basal medium in the amount of from about 0.l to abou~ l0.0 grams per liter, preferably in an amount of about 5 grams per liter.
Albumin or dextran is added to the basal medium in an amount of from about 0.l to about 5.0 grams per liter.
Preferably either bovine serum albumin or dextran having a molecular weight of about 500,000 is added to the basal medium. Bovine serum albumin is preferably added in the amount of from about 0.l to about 0.5 grams per liter.
Dextran having a molecular weight of about 500,000 such as Dextran T500 is preferably added to the basal medium in the amount from about 0.l to about l.0 grams per liter.
Insulin is added to the basal medium in the amount of from about 2.0 to about 20 milligrams per milliliter, preferably in the amount of about l0 milligrams per liter.
Transferrin or transferrin substitute is added to the basal medium in the amount of from about 0 to about l00.0 micrograms per milliliter. Transferrin may be substituted in the medium with ferric fructose (from about l.0 to about l0.0 milligrams per liter), ferric citrate (from about l.0 to about l00.0 milligrams per liter), or ferrous sulfate (from about 5.0 micromoles to about 200.0 micromoles per liter).
A mixture of the fatty acids oleic, linoleic and linolenic are added to the basal medium in the ratio of oleic 0.6: linoleic l: linolenic 0.14 milligrams per liter of medium. In preferred embodiments of the invention, keeping this ratio of fatty acids, oleic acid is preferably added to the basal medium in the amount of from about 0.012 to about 0.12 milligrams per liter; linoleic acid is preferably added to the basal medium in the amount of from about 0.2 to about . . .

~: . . ' . ., ~ ~5~ 2~91443 5.0 milligra~s per liter; linolenic acid is added to the medium in the amount of from about 0.028 to about 0.7 milligrams per liter. Cholesterol is added to the basal medium in t~e amount of from about 0 to about lO.0 milligrams per liter.
In a preferred embodiment of the invention which is described in further detail in Example 2, calcium chloride (CaCl2)(anhydrous) is added to the basal medium in the amount of from about 0 to about 200 milligrams per liter, preferably in the amount of about 66.67 milligrams per liter. Magnesium sulfate (MgSO~)(anhydrous) is added to the basal medium in the amount of from about 0 to about lO0.0 milligrams per liter, preferably in the amount of about 24 milligrams per liter.
The pH of the medium is preferably from abcut 6.8 to about 7.4. The osmolarity of the medium is preferab'y from about 280 to 360 milliosmoles.
The basal medium may be stored as a powder at 4C
for onè year. The complete mediu~ (basal medium with added supplements) in a liyuid form may be stored at 4 C for six months.
Preferred embodiments of the invention are described in the following Examples.
Exa~ple 1 Preparation of B~sAl XeCium The components in the basal media are mixed and ball-mill ground to formulate a homogeneous powder. The powdered media is then dispensed in~o lOOL packets and stored at 4-C.

: : . , - . .

~ . ~

W092/05246 PCT/US91/068~, 1 20914~3 -6~
BASAL MEDIUM COMPONENTS: MRl SERUM-FREE MEDIA
COMPONENTS milligrams/liter INORGANIC SALTS/TRACE ELEMENTS
NaCl 7066.333000 KCL 341.200000 NaH2PO4.H20 93.333000 Na2HPO4 47.347000 MgC12 6H20 4.050000 MgSO4 (anhydrous) 6.510000 CuS04.5H20 0.000866 Fe(NO3)3.9H20 0.000033 FeSO4.7H20 0.278000 ZnS04.7H20 0.287700 MnC12.4H20 0.000033 Na2SeO3 (anhyd) 0.172900 AMINO ACIDS
L-Alanine 41.300000 L-Arginine HCl 112.546700 L-Arginine FB 16.666000 L-Asparagine H20 28.336700 L-Aspartic Acid 24.433300 L-Cystine 2HC1 19.116600 L-Cysteine HCl.H20 45.040000 L-Cysteine FB 13.333300 L-Glutamic Acid 46.566700 L-Glutamine 292.000000 Glycine 35.833300 L-Histidine HCl.H20 20.986700 L-Histidine FB 5.000000 L-Isoleucine 35.480000 L-Leucine 46.833300 L-Lysine HCl 65.486600 L-Methionine 11.493300 L-Phenylalanine 20.653300 L-Proline 34.833300 L-Serine 15.166700 L-Threonine 33.3000D0 L-Tryptophan 7.346700 L-Tyrosine 2Na2H20 36.776700 L-Valine 35.90000C
VITAMINS/MISC. COMPONENTS
Dextrose 4500.000000 Putrescine 2HC1 0.053700 Sodium Pyruvate 81.666700 Ascorbic Acid 17.333300 Biotin 0.202400 D-Calcium Pantothenate 0.160000 Sodium Pantothenate 0.337330 . ., , , ~ . . . . : . :

,. : : . , : . , - ~ : , : :
. .
, , , . ,, . , :
.: .

W092/05246 ~7~ r - I ~ D ~ 1 4 4 3 ~ Choline Chloride 5 486700 Folic Acid 1 100000 i-Inositol 7.333300 Nicotinamide o 679000 Na2 alpha Tocopherol PO4 0 003300 Glutathione (Reduced) 0. 016700 Menadione Na Bisulfite 0 003300 Pyridoxine HCl 0 020700 Pyridoxal HCl 0.666700 Riboflavin 0 079300 Thiamine HCl 0 780000 Vitamin B12 0.973300 Calciferol 0 033300 Methyl Linoleate 0 010000 Vitamin A Acetate 0.033000 Linoleic ~cid 0 028000 Lipoic Acid 0 136700 Preparation of Basal Medium - for a final volume of 100L
Ninety liters of deionized-distilled water is measured into an appropriate mixing vessel. One 100L packet of ball-mill ground powdered media (see above) is added. The pH of the medium is adjusted to 7.2 using lN HCl. The volume of the medium is brought to 100L by the addition of water. The medium may then be sterilized by membrane filtration using a 0.2 micron cellulose acetate filter.
Example 2 Preparation of Medium MR1-3__ Medium MR1-3 contains the basal medium of Example supplemented with 5,000 mg/l TC Yeastolate (Difco, Detroit, Michigan), 500 mg/l bovine serum albumin (BSA) (Armour, Kankakee, Illinais) 10 mg/l bovine insulin (Waitaki, Toronto, Canada), 10 mg/l bovine transferrin (Sigma Chemical Co., St.
Louis, Missouri), 0.12 mg/l oleic acid (Ameresco, Cleveland, Ohio), 0.20 mg/l linoleic acid (Ameresco), 0.028 mg/l linolenic acid (Ameresco), 2 mg/l cholesterol (Ameresco), 66.67 mg/l anhydrous calcium chloride, and 24 mg/l anhydrous magnesium sulfate. The medium is prepared as follows:
~or a final volume of 100L
1. Measure 90 liters of deionized-distilled water into an appropriate mixing vessel.
2. Add one l~OL pac~et of ball-mill ground powdered media (from Example 1).
3. Add 2.4 grams of MgSO4 (anhydrous) and mix until dissolved .
4. Add 6.7 grams of CaCl2 (anhydrous) and mix until - . . : ~ . :

20914~3 -8- ~
dissolved.
5. Add 500 grams of TC Yeastolate, mix until dissolved.
6. Add 50 grams of BSA, mix until dissolved.
7. Add 220 grams of NaHCO3, mix until dissolved.
8. Add l gram of insulin, l gram of transferrin (or l00 ml of ferric fructose) and mix until dissolved.
9. Dissolve 12 mg of Oleic acid, 20 mg of Linoleic acid, 2.8 mg of Linolenic acid, and 200 mg of cholesterol in l00 mls of absolute ethanol, and add this fatty acid mix to the mixing vessel.
l0. Adjust the pH to 7.2 using lN HCl.
ll. Bring the volume to l00 liters and mix thoroughly.
12. Filter sterilize using a 0.2 micron cellulose acetate filter.
13. Check osmolarity and record.
14. Store at 4~C for up to six months.
Example 3 PreParation of Medium MRl-6 Medium MR1-6 is contains the basal medium of Example supplemented with 5,000 mg/l TC Yeastolate (Difco, Detroit, MIchigan), 500 mg/l bovine serum albumin (Armour, Kankakee, Illinois), l0 mg/l bovine insulin (Waitaki, Toronto, Canada), lO mg/l bovine transferrin (Sigma Chemical Co., St. Louis, Missouri), 0.12 ~g/l oleic acid (Ameresco, Cleveland, Ohio), 0.20 mg/l linoleic acid (Ameresco), 0.028 mg/l linolenic acid (Ameresco), and 2 mg/l cholesterol (Ameresco). The medium is prepared in the same way as medium MR1-3 in Example 2 except that steps 3 and 4 are omitted. In this medium no additional MgSO4 or CaClz is added.
Bxa~ple_4 Preparation of Medium MRl-7.
Medium MR1-7 contains the basal medium of Example supplemented with 5,000 mg/l TC Yeastolate (Difco, Detroit, Michigan), l,000 mg/l Dextran T-500 (Pharmacia, Piscataway, New Jersey), l0 mg/l bovine insulin (Waitaki, Toronto, Canada), l0 mg/l bovine transferrin (Sigma Chemical Co, St.
Louis, Missouri), 0.12 mg/l oleic acid (Ameresco, Cleveland, Ohio)j 0.20 mg/l linoleic acid (Ameresco), 0.028 mg/l linolenic acid (Ameresco), and 2 mg/l cholesterol (Ameresco).
Mediun MRl-7 is prepared in the same way as medium MRl-3 in Example 2 except that steps 3 and 4 are omitted and Dextran T-500 replaces bovine serum albumin in step 6. At step 6, l00 grams of Dextran T-500 are added and mixed until dissolved.

,- . ' .: : .: . ' .~
. .
' ':' ' ' - ' :

W092/05246 PCT/US91/06837 l 2~14~3 ~:
~xample S Cell Culture 1' C~O cells transformed to produce soluble T4, a soluble form of the T-4 lymphocytic cell receptor (cell llne 37-80N), were cultured in four different media: serum containing medium Alpha (-) MEM/5% Fetal bovine sexum (FBS), and the media described in Examples 2, 3, and 4. 5 x 105 cells per milliliter were cultured for 7 days after seeding in 250 ml SP flasks with 150 ml of medium. Total cell number was determined by Coulter counter, and viability was determined by trypan blue dye exclusion using a hemocytometer.
Concentration of ST4 was determined by an ELISA-based assay.
At day two after seeding, the serum-free media showed greater number of cells than the serum containing medium. In serum-containing medium, there were approximately 1. 3 X 106 cells, whereas in the serum-free media there were approximately 1.6 x 106 cells. At days 3 through 7 significantly more cells were present in the serum-free media t~an the serum containing medium. At day 3, there were approximately 2.4 x lo6 cells in the serum-containing medium and approximately 3.3 x 106 cells in the serum-free media. At day 4, the total number of cells in the serum-containing medium had dropped slightly to about 2.25 x 106 cells. In contrast, the number of cells in the serum-free media had increased to approximately 3.6 x 106 cells in MR1-7, 4.1 x 106 cells in MR1-3, and 4.3 x 106 cells in MR1-6. By day 7, the total number of cells in medium MRl-7 had increased to approximately 4.0 x 106 cell, and the number of cels in the other med:~.a remained at levels comparable to the levels at day 4.
By three days post seeding, cells grown in the serum-free media produced significantly more sT4 than did cellsgrown in the serum containing medium. The difference in amount of sT4 product became more pronounced at days 4-7. At day 7, cells cultured in the serum free media produced from about 75 to 37 micro~ra~s of sT4 per milliliter o~ medium, whereas cells cultured in the serum containing medium produced about 35 micrograms of sT4 per milliliter of medium.

.
.
.

, - . , ~ .
. ~ , . . . .
:
.

Claims (16)

Claims
1. A serum-free mammalian cell culture medium comprising:
(a) a synthetic basal medium designed for mammalian cell culture;
(b) about 0.1 to about 10 grams per liter hydrolyzed yeast;
(c) about 0.1 to about 5 grams per liter of dextran or albumin;
(d) about 2 to about 20 milligrams per liter insulin;
(e) 0 to about 100 milligrams per liter of a compound selected from the group consisting of transferrin, ferric fructose, ferrous citrate and ferrous sulfate; and (f) a fatty acid component consisting of oleic acid, linoleic acid and linolenic acid in a ratio of about 0.6 : 1 : 0.14 milligrams of fatty acid per liter.
2. The serum free mammalian cell culture medium of claim 1 further comprising 0 to about 10 milligrams per liter cholesterol.
3. The serum-free mammalian cell culture medium of claim 1 further comprising 0 to about 200 milligrams per liter anhydrous calcium chloride and 0 to about 100 milligrams per liter anhydrous magnesium sulfate.
4. The medium of claim 1 wherein said hydrolyzed yeast is present in the medium in the amount of about five grams per liter.
5. The medium of claim 1 wherein albumin is present in said medium in the amount of about 0.5 grams per liter.
6. The medium of claim 5 wherein said albumin is bovine serum albumin.
7. The medium of claim 1 wherein said dextran is present in said medium in the amount of about one gram per liter.
8. The medium of claim 7 wherein said dextran is dextran having a molecular weight of about 500,000.
9. The medium of claim 1 wherein said insulin is present in said medium in the amount of about 10 milligrams per liter.
10. The medium of claim 1 wherein transferrin is present in the amount of about 10 milligrams per liter.
11. The medium of claim 1 wherein oleic acid is present in the amount of about 0.12 milligrams per liter; linoleic acid is present in the amount of about 0.20 milligrams per liter; and linolenic acid is present in the amount of about 0.028 milligrams per liter.
12. The medium of claim 2 wherein cholesterol is present in the amount of about two milligrams per liter.
13. The medium of claim 3 wherein said calcium chloride is present in the amount of about 66 to about 67 milligrams per liter; and magnesium sulfate is present in the amount of about 24 milligrams per liter.
14. A serum-free mammalian cell culture medium comprising:
(a) a synthetic basal medium designed for mammalian cell culture;
(b) about 5 grams per liter hydrolyzed yeast;
(c) about 1 gram per liter of albumin;
(d) about 10 milligrams per liter insulin;
(e) about 10 milligrams per milliliter transferrin;
(f) a fatty acid component consisting of about 0.12 milligrams per liter oleic acid, about 0.20 milligrams per liter linoleic acid and about 0.028 milligrams per liter linolenic acid; and (g) about 2 milligrams per liter cholesterol;
15. The medium of claim 14 further comprising about 66 to about 67 milligrams per liter anhydrous calcium chloride, and about 24 milligrams per liter anhydrous magnesium sulfate.
16. A serum-free mammalian cell culture medium comprising:
(a) a synthetic basal medium designed for mammalian cell culture;
(b) about 5 grams per liter hydrolyzed yeast;
(c) about 1 gram per liter dextran having a molecular weight of about 500,000;
(d) about 10 milligrams per liter insulin;
(e) about 10 milligrams per liter transferrin;
(f) a fatty acid component consisting of about 0.12 milligrams per liter oleic acid, about 0.20 milligrams per liter linoleic acid and about 0.028 milligrams per liter linolenic acid; and (g) about 2 milligrams per liter cholesterol.
CA 2091443 1990-09-25 1991-09-20 Medium for culture of mammalian cells Abandoned CA2091443A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US58801790A 1990-09-25 1990-09-25
US07/588,017 1990-09-25

Publications (1)

Publication Number Publication Date
CA2091443A1 true CA2091443A1 (en) 1992-03-26

Family

ID=24352124

Family Applications (1)

Application Number Title Priority Date Filing Date
CA 2091443 Abandoned CA2091443A1 (en) 1990-09-25 1991-09-20 Medium for culture of mammalian cells

Country Status (11)

Country Link
EP (1) EP0550638A4 (en)
JP (1) JPH06500918A (en)
AU (1) AU662491B2 (en)
CA (1) CA2091443A1 (en)
IE (1) IE913345A1 (en)
MX (1) MX9101254A (en)
NZ (1) NZ239900A (en)
PT (1) PT99048B (en)
TW (1) TW240247B (en)
WO (1) WO1992005246A1 (en)
ZA (1) ZA917561B (en)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE501217C2 (en) * 1990-12-06 1994-12-12 Skandigen Ab Cell proliferation matrix and its use
SE9303601D0 (en) * 1993-11-01 1993-11-01 Kabi Pharmacia Ab Improved cell cultivation method and medium
US6733746B2 (en) 1996-03-12 2004-05-11 Invitrogen Corporation Hematopoietic cell culture nutrient supplement
EP2243827B2 (en) * 1996-08-30 2017-11-22 Life Technologies Corporation Serum-free mammalian cell culture medium, and uses thereof
JP4543402B2 (en) * 1996-10-10 2010-09-15 ライフ テクノロジーズ コーポレーション Animal cell culture medium containing plant-derived nutrients
US6692961B1 (en) 1996-10-11 2004-02-17 Invitrogen Corporation Defined systems for epithelial cell culture and use thereof
ES2256323T5 (en) 2000-11-23 2016-11-21 Bavarian Nordic A/S Variant of the Modified Vaccinia Ankara virus
US7445924B2 (en) 2000-11-23 2008-11-04 Bavarian Nordic A/S Modified Vaccinia Ankara virus variant and cultivation method
EP1434858B2 (en) * 2002-09-05 2018-12-19 Bavarian Nordic A/S Method for the amplification of a poxvirus under serum free conditions
ATE359359T1 (en) * 2003-08-08 2007-05-15 Cambridge Antibody Tech MYELOMA CELL CULTURE IN A TRANSFERRIN-FREE MEDIUM WITH LOW IRON
GB2404665B (en) 2003-08-08 2005-07-06 Cambridge Antibody Tech Cell culture
EP3898943A1 (en) * 2018-12-21 2021-10-27 Genfit In vitro model of liver steatosis and fibrosing non-alcoholic steatohepatitis
CN110343666B (en) * 2019-07-10 2023-05-30 通化东宝药业股份有限公司 Feed supplement culture medium for CHO cell culture and preparation method and application thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2543158B1 (en) * 1983-03-24 1985-11-15 Inst Nat Sante Rech Med MEDIUM FOR CULTURING ANIMAL CELLS WITHOUT SERUM, WITHOUT HORMONES AND WITHOUT GROWTH FACTORS AND METHODS OF PRIMARY CULTURE AND OF OBTAINING CELL LINES USING THE SAME
US5024947A (en) * 1987-07-24 1991-06-18 Cetus Corporation Serum free media for the growth on insect cells and expression of products thereby
DE3801236A1 (en) * 1988-01-18 1989-07-27 Boehringer Mannheim Gmbh PENTOSANE SULFATE MEDIUM
AU4254489A (en) * 1989-10-03 1991-04-11 Ajinomoto Co., Inc. Method of induction and activation of cytotoxic t cells
JP3224539B2 (en) * 1990-09-25 2001-10-29 スミスクライン・ビーチャム・コーポレイション Culture medium for insect cells

Also Published As

Publication number Publication date
AU662491B2 (en) 1995-09-07
EP0550638A1 (en) 1993-07-14
PT99048A (en) 1992-08-31
JPH06500918A (en) 1994-01-27
TW240247B (en) 1995-02-11
EP0550638A4 (en) 1993-12-08
IE913345A1 (en) 1992-02-25
PT99048B (en) 1999-02-26
MX9101254A (en) 1992-05-04
ZA917561B (en) 1992-09-30
NZ239900A (en) 1993-09-27
AU8734891A (en) 1992-04-15
WO1992005246A1 (en) 1992-04-02

Similar Documents

Publication Publication Date Title
US5232848A (en) Basal nutrient medium for cell culture
AU733373B2 (en) Cell culture media for mammalian cells
CN100362098C (en) Non-serum culture medium for multiple animal cell large-scale culture
US5143842A (en) Media for normal human muscle satellite cells
AU662491B2 (en) Medium for culture of mammalian cells
US7462487B2 (en) Cell culture media
EP0501435B1 (en) A serum-free medium for culturing animal cells
CA2248142A1 (en) Hematopoietic cell culture nutrient supplement
KR20070053316A (en) Medium and culture of embryonic stem cells
CN101760442A (en) Serum-free medium for MDCK cell large-scale adherent culture and single-cell suspension culture
JP5431361B2 (en) Improved culture medium additive and method of using the same
CN106190950A (en) A kind of Chinese hamster ovary celI Serum-free and protein-free medium and preparation method thereof
EP0659880B1 (en) Medium for culturing animal cells or antibody-producing cells
CN107435037A (en) A kind of serum free medium for bhk cell
IE921020A1 (en) Serum-free medium for culturing mammalian cells
CN113913368A (en) Serum-free medium suitable for CHO cell large-scale suspension amplification culture and preparation and application thereof
Hanss et al. Studies of culture media for the growth of human tumor cells
Agy et al. Protein-free medium for C-1300 mouse neuroblastoma cells
DE4219250A1 (en) Serum-free cell culture medium
CA2091444C (en) Media for culture of insect cells
JP7166039B1 (en) Peptide, cell growth promoter, protein production promoter, medium, cell growth method using the peptide, and protein production method using the peptide
US5641678A (en) Serum-free culture medium for drosphila insect cells
CN116790477A (en) Serum-free culture medium supporting CHO cell high-density culture and preparation method and application thereof
Donta Growth of functional glial cells in a serumless medium
JPS6233876B2 (en)

Legal Events

Date Code Title Description
EEER Examination request
FZDE Discontinued